isoxsuprine has been researched along with Raynaud Disease in 4 studies
Isoxsuprine: A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ANFOSSI, F | 1 |
| GUARRAGGI, A | 1 |
| Wesseling, H | 2 |
| den Heeten, A | 1 |
| Wouda, AA | 2 |
1 trial available for isoxsuprine and Raynaud Disease
| Article | Year |
|---|---|
Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon.
Topics: Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Hand | 1981 |
3 other studies available for isoxsuprine and Raynaud Disease
| Article | Year |
|---|---|
[CONSIDERATIONS ON THE ACTIVITY OF A VASODILATOR: 1-(P-HYDROXYPHENYL)-2-(1-METHYL-2-PHENOXYETHYLAMINE)-PROPANOL-1-HYDROCHLORIDE (DUVADILAN)].
Topics: 1-Propanol; Arteriosclerosis Obliterans; Cardiovascular Agents; Diabetic Angiopathies; Geriatrics; H | 1964 |
Effects of intravenously administered isoxsuprine in patients with Raynaud's phenomenon.
Topics: Adult; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Hu | 1975 |
Vasodilator drugs and peripheral vascular disease.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Cyclohexanes; Fructose; Humans; Inositol; In | 1972 |